
MedAlliance
Developing ground-breaking technology for the treatment of coronary and peripheral artery disease.
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | $200m Valuation: $325m | Acquisition | |
Total Funding | 000k |

CITIC Capital(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by MedAlliance
Edit
ACQUISITION by MedAlliance Feb 2022